YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Vortioxetine-Induced Amenorrhea: a Case Report

dc.authorid Kurhan, Faruk/0000-0003-3718-0458
dc.authorid Isik, Mesut/0000-0003-1707-7402
dc.authorscopusid 56717384700
dc.authorscopusid 57217966676
dc.authorscopusid 56709613300
dc.authorscopusid 36718861100
dc.authorwosid Ulkevan, Tuba/Mbv-6469-2025
dc.authorwosid Kurhan, Faruk/Ivu-6511-2023
dc.contributor.author Isik, Mesut
dc.contributor.author Kurhan, Faruk
dc.contributor.author Ulkevan, Tuba
dc.contributor.author Ozdemir, Pinar Guzel
dc.date.accessioned 2025-05-10T17:37:18Z
dc.date.available 2025-05-10T17:37:18Z
dc.date.issued 2022
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Isik, Mesut; Kurhan, Faruk; Ulkevan, Tuba; Ozdemir, Pinar Guzel] Van Yuzuncu Yil Univ, Dept Psychiat, Fac Med, Van, Turkey en_US
dc.description Kurhan, Faruk/0000-0003-3718-0458; Isik, Mesut/0000-0003-1707-7402 en_US
dc.description.abstract Background: Vortioxetine is a novel multimodal antidepressant for the treatment of major depressive disorders and is widely used in clinical practice. Vortioxetine has a safe profile. However, there are case reports of other adverse effects in the literature. In this article, a case of amenorrhea due to vortioxetine is presented. Case: The patient is 36 years old, married, female, and is an anesthesiologist. She applied to the psychiatric outpatient clinic with symptoms of major depression. Vortioxetine was initiated at 10 mg/d and then gradually increased to 20 mg/d. She had regular menstruation until now. However, she did not menstruate after taking vortioxetine. The patient used vortioxetine for 3months and never had a period. Pregnancy test and other tests to investigate organic etiology were normal. Twoweeks after discontinuation of vortioxetine, the patient had a menstrual period. Conclusions: Further research is needed on the relationship and possible mechanisms between vortioxetine and amenorrhea. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1097/WNF.0000000000000490
dc.identifier.endpage 8 en_US
dc.identifier.issn 0362-5664
dc.identifier.issn 1537-162X
dc.identifier.issue 1 en_US
dc.identifier.pmid 35029863
dc.identifier.scopus 2-s2.0-85123651377
dc.identifier.scopusquality Q3
dc.identifier.startpage 7 en_US
dc.identifier.uri https://doi.org/10.1097/WNF.0000000000000490
dc.identifier.uri https://hdl.handle.net/20.500.14720/14327
dc.identifier.volume 45 en_US
dc.identifier.wos WOS:000968226900002
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Lippincott Williams & Wilkins en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Vortioxetine en_US
dc.subject Amenorrhea en_US
dc.subject Adverse Effect en_US
dc.title Vortioxetine-Induced Amenorrhea: a Case Report en_US
dc.type Article en_US

Files